Corrigendum to "Genotoxicity of 10 cigarette smoke condensates in four test systems: Comparisons between assays and condensates". [Mutat. Res. 650 (2008) 15-29] (DOI:10.1016/j.mrgentox.2007.09.006);Genotoxicity of 10 cigarette smoke condensates in four test systems: Comparisons between assays and condensates

Mutation Research - Genetic Toxicology and Environmental Mutagenesis

Volumn 650, Issue 1, 2008, Pages 15-29

  DeMarini, David M ^a   Gudi, Ramadevi ^b   Szkudlinska, Anna ^b   Rao, Meena ^b   Recio, Leslie ^c   Kehl, Margaret ^c   Kirby, Paul E ^d   Polzin, Gregory ^e   Richter, Patricia A ^f  

^a U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

^b BioReliance   (United States)

^c INTEGRATED LABORATORY SYSTEMS   (United States)

^d SITEK Research Laboratories   (United States)

^e NATIONAL CENTER FOR ENVIRONMENTAL HEALTH   (United States)

^f NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

Author keywords

Chromosome aberrations; Cigarette smoke condensate; Comet; Micronucleus; Salmonella

Indexed keywords

CARBON MONOXIDE; CIGARETTE SMOKE; NICOTINE; TAR;

ANIMAL CELL; ARTICLE; BACTERIAL STRAIN; CHROMOSOME ABERRATION; CIGARETTE SMOKING; COMET ASSAY; DNA DAMAGE; GENOTOXICITY; LYMPHOMA CELL; MICRONUCLEUS TEST; MOUSE; MUTAGEN TESTING; NONHUMAN; PRIORITY JOURNAL; SALMONELLA; TOBACCO;

NICOTIANA TABACUM; RATTUS; RODENTIA; SALMONELLA;

EID: 38049105474     PISSN: 13835718     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrgentox.2008.02.003     Document Type: Erratum

References (40)

1. DeMarini D.M. Genotoxicity of tobacco smoke and tobacco smoke condensate. Mutat. Res. 114 (1983) 59-89
2. DeMarini D.M. Genotoxicity of tobacco smoke and tobacco smoke condensate: a review. Mutat. Res. 567 (2004) 447-474
3. In: Obe G.G. (Ed). Mutation in Man (1984), Springer, Berlin
4. International Agency for Research on Cancer, Tobacco Smoking, IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans, vol. 38, Lyon, France, 1986.
5. International Agency for Research on Cancer, Tobacco Smoking and Tobacco Smoke, IARC Monographs on the Evaluation of the Carcinogenic Risks of Chemicals to Humans, vol. 83, International Agency for Research on Cancer, Lyon, France, 2004.
6. Sullivan S. The Reference and Research Cigarette Series (1984), University of Kentucky Printing Services, Lexington, KY
7. H.C. Pillsbury, Review of the Federal Trade Commission method for determining cigarette tar and nicotine yield, in: The FTC Cigarette Test Method for Determining Tar, Nicotine, and Carbon Monoxide Yields of U.S. Cigarettes, Report of the NCI Expert Committee, Chapter 2, Monograph 7, National Cancer Institute, National Institutes of Health, 1996, pp. 9-14.
8. Steele R.H., Payne V.M., Fulp C.W., Rees D.C., Lee C.K., and Doolittle D.J. A comparison of the mutagenicity of mainstream cigarette smoke condensates from a representative sample of the U.S. cigarette market with a Kentucky reference cigarette (K1R4F). Mutat. Res. 342 (1995) 179-190
9. Chepiga T.A., Morton M.J., Murphy P.A., Avalos J.T., Bombick B.R., Doolittle D.J., Borgerdng M.F., and Swauger J.E. A comparison of the mainstream smoke chemistry and mutagenicity of a representative sample of the US cigarette market with two Kentucky reference cigarettes (K1R4F and K1R5F). Food Chem. Toxicol. 38 (2000) 949-962
10. Hecht S.S., Murphy S.E., Carmella S.G., Li S., Jensen J., Le C., Joseph A.M., and Hatsukami D.K. Similar uptake of lung carcinogens by smokers of regular, light, and ultralight cigarettes. Cancer Epidemiol. Biomarkers Prev. 14 (2005) 693-698
11. Brinson B. Under the scope. Tobacco Reporter 131 (2004) 16-22
12. Hagiwara Y., Watanabe M., Oda Y., Sofuni T., and Nohmi T. Specificity and sensitivity of Salmonella typhimurium YG1041 and YG1042 strains possessing elevated levels of both nitroreductase and acetyltransferase activity. Mutat. Res. 291 (1993) 171-180
13. Maron D., and Ames B.N. Revised methods for the Salmonella mutagenicity test. Mutat. Res. 113 (1983) 173-215
14. Kirsch-Volders M., Sofuni T., Aardema M., Albertini S., Eastmond D., Fenech M., Ishidate Jr. M., Kirschner S., Lorge E., Morita T., Norppa H., Surralles J., Vanhauwaert A., and Wakata A. Report from the in vitro micronucleus assay working group. Mutat. Res. 540 (2003) 153-163
15. Greenwood S.K., Hill R.B., Sun J.T., Armstrong M.J., Johnson T.E., Gara J.P., and Galloway S.M. Population doubling: a simple and more accurate estimation of cell growth suppression in the in vitro assay for chromosomal aberrations that reduces irrelevant positive results. Environ. Mol. Mutagen. 43 (2004) 36-44
16. Tice R.R., Agurell E., Anderson D., Burlinson B., Hartmann A., Kobayashi H., Miyamae Y., Rojas E., Ryu J.-C., and Sasaki Y.F. The single cell/cell/comet assay: guidelines for in vitro and in vivo genetic toxicology testing. Environ. Mol. Mutagen. 35 (2000) 206-221
17. Galloway S.M., Aardema M.J., Ishidate Jr. M., Ivett J.L., Kirkland D.J., Morita T., Mosesso P., and Sofuni T. Report from the working group on in vitro tests for chromosomal aberrations. Mutat. Res. 312 (1994) 241-261
18. Padma P.R., Amonkar A.J., and Bhide S.V. Mutagenic and cytogenetic studies of N′-nitrosonornicotine and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. Cancer Lett. 46 (1989) 173-180
19. Roemer E., Stabbert R., Rustemeier K., Veltel D.J., Meisgen T.J., Reininghaus W., Carchman R.A., Gaworski C.L., and Podraza K.F. Chemical composition, cytotoxicity and mutagenicity of smoke from US commercial and reference cigarettes smoked under two sets of machine smoking conditions. Toxicology 195 (2004) 31-52
20. Brunnemann K.D., Hoffmann D., Gairola C.G., and Lee B.C. Low ignition propensity cigarettes: smoke analysis for carcinogens and testing for mutagenic activity of the smoke particulate matter. Food Chem. Toxicol. 32 (1994) 917-922
21. DeMarini D.M., Shelton M.L., and Levine J.G. Mutation spectrum of cigarette smoke condensate in Salmonella: comparison to mutations in smoking-associated tumors. Carcinogenesis 16 (1995) 2535-2542
22. White J.L., Conner B.T., Perfetti T.A., Bombick B.R., Avalos J.T., Fowler K.W., Smith C.J., and Doolittle D.J. Effect of pyrolysis temperature on the mutagenicity of tobacco smoke condensate. Food Chem. Toxicol. 39 (2001) 499-505
23. Clapp W.L., Fagg B.S., and Smith C.J. Reduction in Ames Salmonella mutagenicity of mainstream cigarette smoke condensate by tobacco protein removal. Mutat. Res. 446 (1999) 167-174
24. 32P-postlabeling analysis and micronuclei induction in primary Chinese hamster lung cells exposed to tobacco particulate matter. Carcinogenesis 12 (1991) 1507-1514
25. Massey E., Aufderheide M., Koch W., Lodding H., Pohlmann G., Windt H., Jarck P., and Knebel J.W. Micronucleus induction in V79 cells after direct exposure to whole cigarette smoke. Mutagenesis 13 (1998) 145-149
26. Willey J.C., Grafstrom R.C., Moser Jr. C.E., Ozanne C., Sundqvist K., and Harris C.C. Biochemical and morphological effects of cigarette smoke condensate and its fractions on normal human bronchial epithelial cells in vitro. Cancer Res. 47 (1987) 2045-2049
27. Colz L., Krause G., and Scherer G. The comet assay with MCL-5 cells as an indicator of genotoxic treatment with chemicals and cigarette smoke condensate. Altern. Lab. Anim. 30 (2002) 331-339
28. Doolittle D.J., Lee C.K., Ivett J.L., Mirsalis J.C., Riccio E., Rudd C.J., Burger G.T., and Hayes A.W. Comparative studies on the genotoxic activity of mainstream smoke condensate from cigarettes which burn or only heat tobacco. Environ. Mol. Mutagen. 15 (1990) 93-105
29. Lafi A., and Parry J.M. Cytogenetic activities of tobacco particulate matter (TPM) derived from a low to middle tar British cigarette. Mutat. Res. 201 (1988) 365-374
30. L.T. Kozlowski, R.J. O'Connor, C.T. Sweeney, Cigarette design, Smoking and tobacco control monograph No. 13, Risks associated with smoking cigarettes with low machine-measured yields of tar and nicotine, U.S. Department of Health and Human Services, NIH, National Cancer Institute, Bethesda, MD, 2001, pp. 13-38.
31. Zeiger E. Identification of rodent carcinogens and noncarcinogens using genetic toxicity tests: premises, promises, and performance. Regul. Toxicol. Pharmacol. 28 (1998) 85-95
32. Schramke H., Meisgen T.J., Tewes F.J., Gomm W., and Roemer E. The mouse lymphoma thymidine kinase assay for the assessment and comparison of the mutagenic activity of cigarette mainstream smoke particulate phase. Toxicology 227 (2006) 193-210
33. White J.L., Conner B.T., Perfetti T.A., Bombick B.R., Avalos J.T., Fowler K.W., Smith C.J., and Doolittle D.J. Effect of pyrolysis temperature on the mutagenicity of tobacco smoke condensate. Food Chem. Toxicol. 39 (2001) 499-505
34. Mori Y., Iimura K., Furukawa F., Nishikawa A., Takahashi M., and Konishi Y. Effect of cigarette smoke on the mutagenic activation of various carcinogens in hamster. Mutat. Res. 346 (1995) 1-8
35. Laugesen M., and Fowles J. Marlboro ultrasmooth: a potentially reduced exposure cigarette?. Tob. Control 15 (2006) 430-435
36. Rickert W.S., Write W.G., Trivedi A.H., Momin R.A., and Lauterbach J.H. A comparative study of the mutagenicity of various types of tobacco products. Reg. Toxicol. Pharmacol. 48 (2007) 320-330
37. N.L. Benowitz, Compensatory smoking of low-yield cigarettes, Smoking and tobacco control monograph No. 13, Risks associated with smoking cigarettes with low machine-measured yields of tar and nicotine, U.S. Department of Health and Human Services, National Cancer Institute, National Institutes of Health, Bethesda, MD, 2001, pp. 39-63.
38. Harris J.E. Incomplete compensation does not imply reduced harm: yields of 40 smoke toxicants per milligram nicotine in regular filter versus low-tar cigarettes in the 1999 Massachusetts Benchmark Study. Nic. Tobac. Res. 6 (2004) 797-807
39. Hatsukami D.K., Le C.T., Zhang Y., Joseph A.M., Mooney M.E., Carmella S.G., and Hecht S.S. Toxicant exposure in cigarette reducers versus light smokers. Cancer Epidemiol. Biomarkers Prev. 15 (2006) 2355-2358
40. Harris J.E., Thun M.J., Mondul A.M., and Calle E.E. Cigarette tar yields in relation to mortality from lung cancer in the cancer prevention study II prospective cohort, 1982-1988. Br. Med. J. 328 (2004) 2-8